Furthermore, BRCA2-c.1310_1313delAAGA is considered as a North African founder mutation since it has been identified in Algerian, Moroccan and Tunisian breast cancer cases (Cherbal et al., 2010; Fourati et al., 2014; Laarabi et al., 2017). Here, BRCA2 is linked to breast cancer.